Fatty acid synthase regulates the pathogenicity of Th17 cells

J Leukoc Biol. 2017 Nov;102(5):1229-1235. doi: 10.1189/jlb.3AB0417-159RR. Epub 2017 Aug 28.

Abstract

T cell activation and effector function is characterized by changes in metabolism. Altered metabolism is common to almost all types of activated T cells, but fatty acid synthesis seems to especially drive the formation of Th17 cells. Indeed, research has demonstrated that inhibition of early fatty acid synthesis through targeting of acetyl-CoA carboxylase (ACC1) can inhibit Th17 cell formation and instead promote the generation of regulatory T cells. Fatty acid synthase (FASN) is downstream of ACC, and previous studies have shown that FASN activity influences both cancer and inflammation. However, it remains to be determined whether FASN is a viable target for inhibiting Th17 cell function. Here, we demonstrate that FASN is a critical metabolic control for the generation of inflammatory subsets of Th17 cells. Conversely, inhibiting FASN function promotes IFN-γ production by Th1 and Th1-like Th17 cells. In vivo, inhibition of FASN, specifically in Th17 cells, leads to reduction of experimental autoimmune encephalomyelitis disease. These studies demonstrate the necessity of FASN in the autoimmune inflammatory function of Th17 cells.

Keywords: C75; EAE; IFN-γ; IL-17; T lymphocyte.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 4-Butyrolactone / analogs & derivatives
  • 4-Butyrolactone / pharmacology
  • Animals
  • Cell Differentiation
  • Encephalomyelitis, Autoimmune, Experimental / chemically induced
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy
  • Encephalomyelitis, Autoimmune, Experimental / genetics
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Enzyme Inhibitors / pharmacology
  • Fatty Acid Synthase, Type I / antagonists & inhibitors
  • Fatty Acid Synthase, Type I / genetics
  • Fatty Acid Synthase, Type I / immunology*
  • Gene Expression Regulation
  • Humans
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology*
  • Interleukin-17 / genetics
  • Interleukin-17 / immunology*
  • Interleukin-23 / genetics
  • Interleukin-23 / immunology
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Primary Cell Culture
  • Signal Transduction
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / pathology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology
  • Th1 Cells / pathology
  • Th17 Cells / drug effects
  • Th17 Cells / immunology*
  • Th17 Cells / pathology
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 2 / immunology

Substances

  • 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid
  • Enzyme Inhibitors
  • Interleukin-17
  • Interleukin-23
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Tlr2 protein, mouse
  • Toll-Like Receptor 2
  • myelin oligodendrocyte glycoprotein (35-55)
  • Interferon-gamma
  • Fatty Acid Synthase, Type I
  • 4-Butyrolactone